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uring exocytosis, classical and
amino acid neurotransmitters are
released from the lumen of synaptic
vesicles to allow signaling at the synapse.
The storage of neurotransmitters in synaptic vesicles and other types of secretory
vesicles requires the activity of specific vesicular transporters. Glutamate
and monoamines such as dopamine
are packaged by VGLUTs and VMATs
respectively. Changes in the localization of either protein have the potential
to up or downregulate neurotransmitter
release, and some of the mechanisms for
sorting these proteins to secretory vesicles have been investigated in cultured
cells in vitro. We have used Drosophila
molecular genetic techniques to study
vesicular transporter trafficking in an
intact organism and have identified a
motif required for localizing Drosophila
VMAT (DVMAT) to synaptic vesicles in
vivo. In contrast to DVMAT, large deletions of Drosophila VGLUT (DVGLUT)
show relatively modest deficits in localizing to synaptic vesicles, suggesting that
DVMAT and DVGLUT may undergo
different modes of trafficking at the synapse. Further in vivo studies of DVMAT
trafficking mutants will allow us to determine how changes in the localization of
vesicular transporters affect the nervous
system as a whole and complex behaviors
mediated by aminergic circuits.
The initiation and termination of synaptic
transmission requires two types of neurotransmitter transporters. Plasma membrane transporters mediate the reuptake
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of transmitter from the synaptic cleft into
either the presynaptic terminal or adjacent
glia following exocytosis.1-3 These proteins
thereby help to determine the amount of
neurotransmitter that is available for signaling at the synapse.3 The structurally
and bioenergetically distinct vesicular
transporters are responsible for the storage
of neurotransmitters in synaptic vesicles
(SVs) as well as other types of secretory
vesicles.4,5 These include specific vesicular
transporters for acetylcholine (VAChT),
GABA and glycine (VGAT/VIAAT),
glutamate (VGLUTs), purine nucleotides
(VNUT) 6 and the monoamines serotonin,
dopamine, noradrenalin, histamine and in
invertebrates, octopamine (VMATs).4,5 A
variety of papers published over the past
fifteen years have shown that vesicular
transporter expression, and the number of
transporters that localize to each vesicle,
can regulate the amount of neurotransmitter that is stored and released during exocytosis.7 Increasing the number
of transporters on each vesicle may also
influence the well-described electrophysiological parameter of quantal size, defined
as the amplitude of a post-synaptic signal
generated by a single vesicle’s content of
neurotransmitter.7 Changes in quantal
size have classically been considered to be
strictly the domain of post-synaptic receptors and their attendant signaling machinery. The idea that quantal size might be
regulated by vesicular transporters opens
up a host of interesting possibilities
including the possible presynaptic scaling of coordinated circuits in the central
nervous system.8,9
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In addition to increased expression,
membrane trafficking represents another
mechanism to regulate the number of
transporters that localize to each vesicle.10,11 Membrane trafficking also adds
the possibility of regulated sorting of
transporters to different types of secretory
vesicles. In addition to synaptic vesicles
(SVs), which cluster at specific sites in the
nerve terminal, monoamines and perhaps
other types of neurotransmitters can be
released from the more diffusely localized large dense core vesicles (LDCVs),
which also release peptide transmitters.
It is possible that regulated events such as
transporter phosphorylation could control
the number of transporters that localize
to LDCVs versus SVs.12,13 In addition, it
is possible that vesicular transporters distribute to different subclasses of SVs at
the nerve terminal. It has been known for
decades that VAChT localizes to at least
two biochemically distinct populations of
vesicles at the neuromuscular junction.14,15
Other vesicular transporters may also sort
to functionally distinct pools of SVs.16 It is
not yet clear whether distribution to subsets of SVs can be regulated via membrane
trafficking, but there are a few tantalizing clues suggesting that this may indeed
occur.15,17
The potential contribution of v esicular
transporter trafficking to neurotransmitter release increases the importance
of understanding the basic cellular
mechanisms that sort the transporters to
secretory vesicles. Some of the cellular
machinery has been identified and appears
to be identical to evolutionarily conserved
proteins required for vesicle budding and
fusion throughout the cell.10,18 For “cargo,”
such as the vesicular transporters to be
included in a particular budding vesicle,
“sorting signals” must be encoded in the
primary structure of the protein or added
post-translationally. The signals required
for protein trafficking in non-neuronal
cells have been extensively characterized.19
However, the sorting signals that allow
vesicular transporters and other proteins
to localize to secretory vesicles are less
clearly defined. It also remains unclear
whether different vesicular transporters
use the same or different pathways to get
to SVs at the nerve terminal. We are using
the fly to help address these questions and
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in particular, to determine which signals
are needed for sorting to secretory vesicles
in vivo. In time, these studies will allow
us to determine how vesicular transporter
trafficking may influence normal and disease-related behaviors and the physiology
of the nervous system as a whole.
Most current models of SV trafficking
indicate that endocytosis from the cell surface is somehow required, thus predicting
that endocytosis signals in vesicular transporters should have an important role in
sorting the transporters to SVs.20 Several
studies have already identified signals on
vesicular transporters that are important
for both endocytosis and trafficking to
SVs in cultured cells.10 The neural isoform
of the mammalian vesicular monoamine
transporter (VMAT2) contains a dileucine
motif that is necessary for both internalization from the cell surface and localization
to synaptic-like microvesicles (SLMVs) in
PC12 cells.21,22 A similar motif and possibly an additional tyrosine-based signal
allows VAChT to internalize from the cell
surface and localize to SLMVs in neuroendocrine cells.23-25 A variant of the dileucine
motif (FV), and in some cases a polyproline motif may be important for recycling
mammalian VGLUTs to SVs in cultured
cells.26 These studies notwithstanding, the
trafficking of vesicular transporters in vivo
has remained relatively obscure.
As a first step toward determining how
transporter trafficking might affect the
function of the nervous system as a whole,
we set out to identify trafficking motifs
in the Drosophila orthologs DVMAT
and DVGLUT.27-29 For DVMAT, we
focused on DVMAT-A, the splice variant expressed in all aminergic neurons.28,30
(Another splice variant, DVMAT-B, is
expressed in a small subset of glia in the
visual system and contains a distinct trafficking domain).31 We find that a tyrosine
in the carboxy terminus of DVMAT-A
(Y600) is necessary for efficient endocytosis in vitro.29 This signal is likely to be
similar to the canonical tyrosine-based
motif YXXΦ, where Φ represents a bulky
hydrophobic residue.19 To determine
whether this signal would affect targeting of DVMAT-A to synaptic vesicles in
vivo, we generated transgenes containing
the wild type protein and others containing mutations in the putative trafficking
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domain. Using biochemical fractionation
of adult head homogenates, we showed
that mutation of Y600 or deletion of the
entire carboxy terminus dramatically
reduces the localization of DVMAT-A to
SVs. To our knowledge, these findings are
the first to show that mutation of a trafficking motif in a vesicular transporter or
any vesicular protein can disrupt localization to secretory vesicles in vivo. We
are now investigating whether additional
motifs might function as back-up signals
for trafficking of DVMAT-A to SVs via
alternative 
pathways, or for sorting to
LDCVs.
In parallel with our studies on
DVMAT, we have used both biochemical
and genetic methods to study the trafficking of DVGLUT. The Drosophila genome
contains one VGLUT ortholog, thus facilitating the genetic analysis of glutamate
release and signaling.27,32 Overexpression
of DVGLUT can increase quantal size and
the resultant increase in glutamate release
is lethal (Daniels RW and DiAntonio AD,
unpublished). Screening for intragenic
mutations that suppressed lethality led to
the isolation of a number of DVGLUT
variants with missense or nonsense mutations in potential trafficking domains. In
addition, we used in vitro mutagenesis to
more directly disrupt proposed trafficking domains. Using mutants derived from
both in vitro mutagenesis and in vivo
screening, we then showed that large deletions of the DVGLUT C-terminal trafficking domain had very modest effects on
either internalization in cultured cells in
vitro, or on DVGLUT’s localization to SVs
in vivo. Previous studies have shown that
mutation of proposed trafficking domains
in mammalian VGLUTs similarly result
in relatively subtle effects on internalization in cultured cells.26,33,34 Based on these
differences, we speculated that the pathways that sort VMATs and VGLUTs to
SVs at the synapse might be significantly
different.29 This idea is supported by a
recent demonstration that mammalian
VMAT2 and VGLUT1 may undergo
endocytosis to different 
populations of
SVs in m
 ammalian neurons.16
The relative resistance of VGLUTs
to the disruption of canonical trafficking motifs raises the possibility that VGLUTs could employ novel
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trafficking mechanisms. Lumenal and
transmembrane domains help sort pro
teins to the apical surface of polarized epithelia,35 and it is conceivable that similar
signals play a role in transporter trafficking at the synapse. In addition, a subset
of mutations in a cytosolic loop domain
of DVGLUT appear to disrupt exit from
the soma.29 Further study of these mutants
may help disentangle non-specific changes
in protein structure from potentially more
interesting effects on trafficking.
In ongoing studies, we are testing the
behavioral affects of disrupting transporter trafficking. We have recently shown
that dVMAT mutants exhibit several deficits in monoamine-linked behaviors.36 To
determine how DVMAT trafficking may
influence behavior, we are genetically rescuing the dVMAT mutant with a panel
of transgenes containing altered trafficking signals. As described for DVGLUT,29
forward genetic screens may be used to
study trafficking of DVMAT or other
vesicular transporters such as DVGAT37
and DVAChT.38 In addition to identifying
important motifs within the transporters
themselves, future genetic screens may
also be used to identify interacting proteins possibly important for trafficking.
This type of screen was recently used to
identity a binding partner for the C. elegans ortholog of VAChT.39
Since the mechanisms of 
neurotransmitter transport and release are
highly conserved, our studies in the fly
may provide important clues about the
potential contribution of transporter trafficking to human behavior and disease.
Several recent papers suggest that mutations in plasma membrane neurotransmitter transporters may be linked to specific
neuropsychiatric syndromes.40 Alterations
in VMAT2 expression have also been tentatively linked to neuropsychiatric illness41
and Parkinson’s disease42 and the overexpression of both VMAT2 and DVMAT-A
can have neuroprotective effects.43,44 The
ability of VMATs to confer neuroprotection against the toxic effects of amphetamines has been proposed to depend on
the localization of VMAT2 to SVs.45 We
are currently investigating whether mutations in DVMAT trafficking motifs ablate
its ability to confer neuroprotection in
the fly. More generally, we speculate that
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our studies of transporter trafficking
in Drosophila may help determine how
changes in neurotransmitter storage and
release contribute to the pathophysiology
and treatment of a variety of disease states.
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